These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8535647)

  • 1. Clinical efficacy of sulphasalazine--a review.
    Capell HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
    Haagsma CJ; van Riel PL; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():104-8. PubMed ID: 8535640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies with salazopyrine--consequences and perspectives].
    Zeidler H
    Z Rheumatol; 1987; 46(2):59-66. PubMed ID: 2885985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
    Shiroky JB
    J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
    Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P
    J Rheumatol; 1999 Mar; 26(3):712-6. PubMed ID: 10090188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
    Schipper LG; Fransen J; Barrera P; Van Riel PL
    Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How and when should combination therapy be used? The role of an anchor drug.
    Farr M; Bacon PA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():100-3. PubMed ID: 8535639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
    Kahan A; Menkès CJ
    Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism.
    Cronstein BN
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():30-2. PubMed ID: 8535646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.
    Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA
    J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
    Anderson JJ; Wells G; Verhoeven AC; Felson DT
    Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The history of the use of sulphasalazine in rheumatology.
    Amos RS
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Armentarium and strategies for the treatment of rheumatoid arthritis].
    Lioté F
    Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
    Berthelot JM; Saraux A; Maugars Y; Prost A; Le Goff P
    Rev Rhum Engl Ed; 1999 Apr; 66(4):224-8. PubMed ID: 10339779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.